![These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA® ( aflibercept) Injection, for intravitreal use Initial U.S. Approval: 2011 These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA® ( aflibercept) Injection, for intravitreal use Initial U.S. Approval: 2011](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=eylea-01.jpg&id=730449)
These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA® ( aflibercept) Injection, for intravitreal use Initial U.S. Approval: 2011
WVU Eye Institute retinopathy of prematurity clinical trial results in FDA approval | School of Medicine | West Virginia University
UNITED STATES INTERNATIONAL TRADE COMMISSION WASHINGTON, D.C. In the Matter of CERTAIN PRE-FILLED SYRINGES FOR INTRAVITREAL INJE
![These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA® ( aflibercept) Injection, for intravitreal use Initial U.S. Approval: 2011 These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA® ( aflibercept) Injection, for intravitreal use Initial U.S. Approval: 2011](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=eylea-14.jpg&id=730449)